Royal Bank of Canada’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $678K | Buy |
308,551
+287,730
| +1,382% | +$632K | ﹤0.01% | 3911 |
|
2025
Q1 | $24K | Sell |
20,821
-5,966
| -22% | -$6.88K | ﹤0.01% | 5468 |
|
2024
Q4 | $34K | Sell |
26,787
-141
| -0.5% | -$179 | ﹤0.01% | 5380 |
|
2024
Q3 | $91K | Sell |
26,928
-874
| -3% | -$2.95K | ﹤0.01% | 4954 |
|
2024
Q2 | $129K | Buy |
27,802
+6,572
| +31% | +$30.5K | ﹤0.01% | 4721 |
|
2024
Q1 | $159K | Sell |
21,230
-21,121
| -50% | -$158K | ﹤0.01% | 4440 |
|
2023
Q4 | $429K | Buy |
42,351
+129
| +0.3% | +$1.31K | ﹤0.01% | 3896 |
|
2023
Q3 | $330K | Buy |
42,222
+12,844
| +44% | +$100K | ﹤0.01% | 3898 |
|
2023
Q2 | $242K | Buy |
29,378
+7,188
| +32% | +$59.2K | ﹤0.01% | 4156 |
|
2023
Q1 | $161K | Sell |
22,190
-51,265
| -70% | -$372K | ﹤0.01% | 4428 |
|
2022
Q4 | $652K | Sell |
73,455
-2,930
| -4% | -$26K | ﹤0.01% | 3433 |
|
2022
Q3 | $935K | Buy |
76,385
+2,154
| +3% | +$26.4K | ﹤0.01% | 3088 |
|
2022
Q2 | $879K | Sell |
74,231
-2,621
| -3% | -$31K | ﹤0.01% | 3224 |
|
2022
Q1 | $1.46M | Buy |
76,852
+15,684
| +26% | +$298K | ﹤0.01% | 2923 |
|
2021
Q4 | $1.63M | Buy |
61,168
+9,434
| +18% | +$251K | ﹤0.01% | 2899 |
|
2021
Q3 | $2.13M | Sell |
51,734
-10,791
| -17% | -$443K | ﹤0.01% | 2638 |
|
2021
Q2 | $3.54M | Buy |
62,525
+12,087
| +24% | +$685K | ﹤0.01% | 2258 |
|
2021
Q1 | $2.12M | Sell |
50,438
-69,457
| -58% | -$2.92M | ﹤0.01% | 2584 |
|
2020
Q4 | $8.41M | Buy |
119,895
+57,666
| +93% | +$4.04M | ﹤0.01% | 1597 |
|
2020
Q3 | $1.75M | Sell |
62,229
-2,857
| -4% | -$80.2K | ﹤0.01% | 2434 |
|
2020
Q2 | $1.93M | Buy |
65,086
+6,786
| +12% | +$201K | ﹤0.01% | 2308 |
|
2020
Q1 | $1.16M | Buy |
58,300
+1,185
| +2% | +$23.5K | ﹤0.01% | 2538 |
|
2019
Q4 | $1.69M | Sell |
57,115
-8,524
| -13% | -$252K | ﹤0.01% | 2535 |
|
2019
Q3 | $1.49M | Buy |
65,639
+239
| +0.4% | +$5.44K | ﹤0.01% | 2521 |
|
2019
Q2 | $1.62M | Buy |
65,400
+4,005
| +7% | +$99.1K | ﹤0.01% | 2471 |
|
2019
Q1 | $1.5M | Buy |
61,395
+9,913
| +19% | +$242K | ﹤0.01% | 2447 |
|
2018
Q4 | $1.17M | Sell |
51,482
-2,675
| -5% | -$60.8K | ﹤0.01% | 2522 |
|
2018
Q3 | $1.72M | Buy |
54,157
+41
| +0.1% | +$1.3K | ﹤0.01% | 2470 |
|
2018
Q2 | $1.94M | Buy |
54,116
+16,500
| +44% | +$591K | ﹤0.01% | 2306 |
|
2018
Q1 | $1.25M | Buy |
37,616
+17,494
| +87% | +$580K | ﹤0.01% | 2505 |
|
2017
Q4 | $619K | Buy |
20,122
+6,264
| +45% | +$193K | ﹤0.01% | 2991 |
|
2017
Q3 | $333K | Buy |
13,858
+4,494
| +48% | +$108K | ﹤0.01% | 3462 |
|
2017
Q2 | $157K | Buy |
9,364
+372
| +4% | +$6.24K | ﹤0.01% | 3811 |
|
2017
Q1 | $201K | Buy |
8,992
+2,496
| +38% | +$55.8K | ﹤0.01% | 3716 |
|
2016
Q4 | $105K | Buy |
6,496
+3,517
| +118% | +$56.8K | ﹤0.01% | 4105 |
|
2016
Q3 | $40K | Buy |
2,979
+2,429
| +442% | +$32.6K | ﹤0.01% | 4509 |
|
2016
Q2 | $13K | Sell |
550
-4,175
| -88% | -$98.7K | ﹤0.01% | 4946 |
|
2016
Q1 | $164K | Buy |
+4,725
| New | +$164K | ﹤0.01% | 3840 |
|